Serum A-FABP is increased and closely associated with elevated NT-proBNP levels in type 2 diabetic patients treated with rosiglitazone.
about
Associations of A-FABP with Anthropometric and Metabolic Indices and Inflammatory Cytokines in Obese Patients with Newly Diagnosed Type 2 Diabetes.Measuring non-polyaminated lipocalin-2 for cardiometabolic risk assessment.Circulating adipocyte fatty acid-binding protein levels are independently associated with heart failure.
P2860
Serum A-FABP is increased and closely associated with elevated NT-proBNP levels in type 2 diabetic patients treated with rosiglitazone.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Serum A-FABP is increased and ...... ts treated with rosiglitazone.
@ast
Serum A-FABP is increased and ...... ts treated with rosiglitazone.
@en
Serum A-FABP is increased and ...... ts treated with rosiglitazone.
@nl
type
label
Serum A-FABP is increased and ...... ts treated with rosiglitazone.
@ast
Serum A-FABP is increased and ...... ts treated with rosiglitazone.
@en
Serum A-FABP is increased and ...... ts treated with rosiglitazone.
@nl
prefLabel
Serum A-FABP is increased and ...... ts treated with rosiglitazone.
@ast
Serum A-FABP is increased and ...... ts treated with rosiglitazone.
@en
Serum A-FABP is increased and ...... ts treated with rosiglitazone.
@nl
P2093
P2860
P1433
P1476
Serum A-FABP is increased and ...... ts treated with rosiglitazone.
@en
P2093
P2860
P304
P356
10.1371/JOURNAL.PONE.0027032
P407
P577
2011-10-28T00:00:00Z